Pattern Recognition Algorithms in Pharmacogenomics and Drug Repurposing-Case Study: Ribavirin and Lopinavir

Area of Science:

• Computational biology and bioinformatics
• Pharmacogenomics and drug discovery
• Artificial intelligence in medicine

Background:

• Pattern recognition and machine learning are crucial for analyzing complex biomedical data in drug discovery.
• These techniques are increasingly applied in pharmacogenomics and computational drug repurposing.
• Understanding genetic influences on drug response and identifying new uses for existing drugs are key challenges.

Purpose of the Study:

• To review state-of-the-art pattern recognition techniques in pharmacogenomics and drug repurposing.
• To illustrate applications using case studies like ribavirin and lopinavir for COVID-19.
• To discuss current limitations and future directions in the field.

Main Methods:

• Review of traditional machine learning (e.g., SVM), deep learning, Genome-Wide Association Studies (GWAS), and biomarker discovery.
• Analysis of pharmacogenomic data for predicting drug response.
• In silico screening and AI-assisted identification of repurposed drugs.

Main Results:

• Demonstrated success in machine learning-driven prediction of drug responders.
• Highlighted AI's role in identifying repurposed drugs, such as baricitinib for COVID-19.
• Identified limitations including data scarcity, model interpretability, and translational gaps.

Conclusions:

• Pattern recognition algorithms show significant promise for advancing precision medicine and accelerating drug discovery.
• Integrating multi-omics data and improving algorithmic interpretability are crucial future steps.
• Enhanced synergy between computational predictions and experimental validation is needed to overcome challenges and realize the full potential.